Evaluate the benefit of using liposomal bupivicaine in lumbar laminectomies in terms of length of stay, IV narcotic use, 30-day narcotic use, visual analog score (VAS) and 30-day readmissions
Recent evidence suggests the use of liposomal bupivicaine (LB) in lumbar spine surgery shortens length of hospital stay and overall post-operative narcotic use. Studies have shown its utility in single level microdiscectomies and lumbar fusions, but there have been no publications regarding lumbar laminectomies and associated outcomes with LB. The investigators' hypothesis is that LB will significantly shorten inpatient stays as well as overall narcotic usage in single, double or multi-level lumbar laminectomies.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
100
Injection of either liposomal bupivicaine or standard local anesthetic during surgical procedure.
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
RECRUITINGOverall length of hospital stay from hospital admission to hospital discharge
Length of stay will be measured in hours
Time frame: From date of hospital admission until date of hospital discharge, assessed up to 2 weeks.
IV narcotic usage
Tracked by patient's electronic medical record
Time frame: From date of hospital admission until date of hospital discharge, assessed up to 2 weeks.
30-day narcotic usage
Narcotic usage will be assessed via state narcotic databases.
Time frame: 30-day post surgery
Change in Visual Analog Pain scale scores
The scale is called the Visual Analog Pain scale. This scale provides a measure of the patient's reported level of pain . Patients will be asked to rate their pain level using the Visual Analog Pain scale. This scale uses numbers, 1-10, with 1 being no pain and 10 being the worst pain. It also uses faces depicting no pain up to the worst pain. Lower reported scores indicate the patient has little to no pain, which is desirable.
Time frame: Screening, Day of Procedure, Prior to Hospital Discharge (Post-op, Up to 2 weeks), Up to 30-days post-surgery (Follow-Up#1) and up to 12-months post-op follow up
30-day readmission rates
Occurrences of readmission will be tracked by patient's electronic medical record
Time frame: Day 30
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.